Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth
Peer-Reviewed Publication
This month, we’re spotlighting colorectal cancer research in recognition of National Colorectal Cancer Awareness Month. Here, we’ll share the latest research on colorectal cancer, how scientists work to better understand and prevent it, what screening options are available, and what these findings may mean for protecting your health, and more.
Updates every hour. Last Updated: 5-Mar-2026 06:14 ET (5-Mar-2026 11:14 GMT/UTC)
In a new study published in Science Signaling, University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells.
Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.
A transformative $10 million gift from Cynthia King, the late Jeffery King, and Jason and Julie Borrelli launches the King Center for Lynch Syndrome at the Abramson Cancer Center of the University of Pennsylvania.
The American College of Surgeons has released free, publicly available educational materials and a checklist to help people recognize potential warning signs of colorectal cancer and prepare for primary care visits.
Scientists have identified a new way to distinguish healthy guts from diseased ones and track how some illnesses progress by measuring how gut bacteria interact with one another.
According to a study published in Science, a collaboration between scientists at Rutgers University, Universidad de Granada in Spain and Princeton University found that healthy and diseased gut microbiomes behave like two distinct ecological states, driven not by individual microbes but by how entire bacterial communities compete and cooperate.